A new phase-contrast CR mammography system that magnifies edge effects from x-ray refraction is sharpening contrast at the edges of the breast. The system, unveiled today at the RSNA meeting, also enhances the visualization of microcalcifications and fibrils within the breast, according to representatives from Konica Minolta.
A new phase-contrast CR mammography system that magnifies edge effects from x-ray refraction is sharpening contrast at the edges of the breast. The system, unveiled today at the RSNA meeting, also enhances the visualization of microcalcifications and fibrils within the breast, according to representatives from Konica Minolta.
The Regius PureView Mammography System combines phase-contrast mammography technology with computed radiography to produce digital mammography images with the same resolution as screen-film images.
The device uses a molybdenum x-ray tube with a 100-micron focal spot. The system also selects the optimal combination of x-ray focal spot size, the distance between the x-ray source and the breast, the distance between the x-ray source and the detector, and the sampling pitch of the CR reader, which scans images at 43.75 micrometers to produce a resolution of 20 line pair per millimeter.
The CR mammography system, which was introduced 10 months ago in Japan, is being tested in clinical trials prior to submission to the FDA for approval.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
Contrast-Enhanced Mammography Study Reveals 24 Percent Lower Sensitivity with Moderate/Marked BPE
April 30th 2025In comparison to minimal or mild background parenchymal enhancement on contrast-enhanced mammography (CEM), researchers found that moderate or marked BPE was associated with a 12 percent lower AUC for breast cancer detection.